NorthWest Biotherapeutics Inc (NWBO)

[Lykiri]

Flipper,
You say:
______________________________________________________________________________
Quote:
"Four important things happened over the last couple weeks.

1. Cognate management completed buyout of its own company from Toucan. An international "syndicate" helped resource Cognate buyout from Toucan. It was a friendly buyout that was reportedly years in the making.

2. Astra Zeneca received approval for checkpoint inhibitor "Imfinzi" in stage III unresectable lung cancer that does not (and/or no longer) responds to chemotherapy. No foreseeable competition for that indication in the near future. (I'd call that a foot in the door.)

3. NWBO Board member Navid Malik (Neil Woodford friend) was allocated 9,065,000 of options from NWBO Directors. (Woodford fund's largest investment is Astra Zeneca)

4. Advent is transferring (aka: "migrating") its facilities from NW London to Sawston over the next 18 months.

(Note: UK's NICE has not changed it's plan to start DCVax-L appraisal this coming summer ("Begins" Mid June, 2018. NICE UK has announced/designated June 2018 since last August 2017)"
______________________________________________________________________________

I don’t understand point 3 about Mr.Navid Malik. (https://www.nwbio.com/northwest-bio-welcomes-new-additions-to-the-board-of-directors/).

Can you explain why it’s so important for you dat NWBO Board member Navid Malik was allocated 9,065,000 of options from NWBO Directors!( http://ih.advfn.com/p.php?pid=nmona&article=76855792)

We know that Mr. Navid Malik introduced Mr Woodford to Northwest Biotherapeutics.

Source :” Mr Cooper was concerned not only by the Claimant's undisclosed shareholding but also about the possibility that the Claimant had been more involved in the day-to-day dealings of NWB than he had led the Respondent to believe and that the Claimant may have introduced Mr Woodford of WIM to NWB. That could give rise to a conflict of interest.
(e) Mr Phillips interviewed the Claimant on 7 and 21 October 2015 about his involvement with NWB. During the course of those meetings, the Claimant accepted that he was a shareholder of NWB and that he had introduced WIM to NWB. Notwithstanding this, the Claimant was not suspended at that time."

https://www.employmentcasesupdate.co.uk/site.aspx?i=ed36861

On the other hand we know that Cenkos have a strong relationship with Neil Woodford, which has generated a lot of business for them.

From the same source:” Mr Hodges was influenced by the Claimant's relationship with an institutional investor with whom the Respondent worked regularly, Mr Woodford of Woodford Investment Management(WIM)".

https://www.employmentcasesupdate.co.uk/site.aspx?i=ed36861

On October 2015 the Phase V report came to our attention.
On November 4, 2015 Mr.Malik, head of life sciences research at Cenkos Securities, has been suspended with pay while the stock broker investigates the allegation.

Mr. Malik lost his employment case as plaintiff against Cenkos.

https://www.gov.uk/employment-appeal-tribunal-decisions/dr-n-malik-v-cenkos-securities-plc-ukeat-0100-17-rn
https://www.warnergoodman.co.uk/news/employment-law-case-update-malik-v-cenkos-securities-plc

Strange story. On the one hand you have the good relationship between Mr Malik and N. Woodford, and on the other hand, you have the business relation between N.Woodford and Cenkos. Looks like a conflict of interest. Any Thoughts???